[Translation] Phase I clinical trial of single dose escalation of meditinib sulfate tablets in newly-treated chronic myeloid leukemia subjects in chronic phase
The main purpose of this study was to investigate the tolerability and safety of a single oral dose of meditinib sulfate tablets in chronic myeloid leukemia subjects in the chronic phase of treatment-naïve chronic myeloid leukemia; Pharmacokinetic characteristics of single oral administration of meditinib sulfate tablets in humans.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.